Headache and Concomitant Disorders: Diagnosis, Treatment and Management

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: closed (31 May 2021) | Viewed by 4050

Special Issue Editors


E-Mail Website
Guest Editor
Department of Health Sciences, Universidad de Jaén, Jaen, Spain
Interests: posture; postural balance; vestibular diseases; rehabilitation; manual therapy; headache; migraine; neck pain; temporomandibular joint disorders; fibromyalgia
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Health Sciences, Universidad de Jaén, Jaén, Spain
Interests: chronic pain; musculoskeletal pain; conditioned pain modulation; fibromyalgia syndrome; postural balance; manual therapy; virtual-reality-based therapy
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Headaches are a significant public health problem in countries of all development levels and have an enormous economic and social impact. The diagnosis, according to the criteria of the International Classification of Headache Disorders (ICHD) third edition, is not simple and it always requires a detailed knowledge of the clinical history, a comprehensive evaluation of the nervous system and a physical examination of all related structures. In the context of the different and not always well-known mechanisms behind headaches at the molecular level, we would like to emphasize the role that other concomitant problems could have on headaches, such as sleep disorders, neck pain, cranium–vertebral or trigeminal interactions.

We invite investigators to contribute original research, such as observational, experimental or validation studies, systematic reviews and meta-analyses, as well as case series and case reports that focus on how these interactions at the molecular level affect the correct management, both diagnostically and therapeutically, of headaches.

Potential topics may include (but are not limited to): the clinical and molecular association between headaches and other systems or disorders; the function of biomarkers in headache diagnosis; the biological effects of physiotherapy, therapeutic exercise or pharmacological treatment on patients with headaches or related disorders in the cranium–cervical region; and new advances in the diagnosis, pathophysiological mechanisms or treatment of headaches.

Prof. Rafael Lomas-Vega
Dr. María Catalina Osuna-Pérez
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • headache
  • migraine disorders
  • headache diagnosis
  • biomarkers
  • neck pain
  • craniomandibular disorders
  • pharmacological treatment
  • physiotherapy
  • evaluation studies
  • reproducibility of results

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 1199 KiB  
Article
Features and Management of New Daily Persistent Headache in Developmental-Age Patients
by Laura Papetti, Giorgia Sforza, Samuela Tarantino, Romina Moavero, Claudia Ruscitto, Fabiana Ursitti, Michela Ada Noris Ferilli, Federico Vigevano and Massimiliano Valeriani
Diagnostics 2021, 11(3), 385; https://doi.org/10.3390/diagnostics11030385 - 24 Feb 2021
Cited by 10 | Viewed by 3318
Abstract
Introduction. Our aim was to investigate the clinical features of primary new daily persistent headache (NDPH) in a cohort of paediatric patients. Methods. We reviewed the data of patients with persistent daily headache, attending the Headache Centre of Bambino Gesù Children from the [...] Read more.
Introduction. Our aim was to investigate the clinical features of primary new daily persistent headache (NDPH) in a cohort of paediatric patients. Methods. We reviewed the data of patients with persistent daily headache, attending the Headache Centre of Bambino Gesù Children from the January 2009. The ICHD-III criteria were used for diagnosis. Statistical analysis was conducted to study possible correlations between NDPH and population features (age and sex), NDPH and headache qualitative features, and NDPH and response to pharmacological therapies. Results. We included 46 subjects with NDPH. The features of pain more closely resembled those of migraine than to those of tension-type headache (62 vs. 38%). The NDPH patients showed nausea and vomiting less frequently than migraine ones (28.6 vs. 48.2%, p < 0.01). A total of 75% of NDPH patients experienced an onset of the symptoms in the winter months (November to February) (p < 0.01). NDPH was less common in very young children under 10 years of age. Almost 58% of NDPH patients received pharmacological therapy and the most used drug was amitriptyline. A reduction of attacks by at least 50% in a month was detected in 30.6% of patients. Conclusions. NDPH can be very disabling and correlates with seasonal factors. Although long term pharmacological therapy is recommended, considering the long duration that this headache can have, there are no data supporting the treatment choice. Full article
Show Figures

Figure 1

Back to TopTop